Corticosteroid Use in Otolaryngology: Current Considerations During the COVID-19 Era.

C W David Chang,Edward D McCoul,Selena E Briggs,Elizabeth A Guardiani,Marlene L Durand,Tessa A Hadlock,Alexander T Hillel,Nrusheel Kattar,Peter J M Openshaw,Nosayaba Osazuwa-Peters,David M Poetker,Jennifer J Shin,Sujana S Chandrasekhar,Carol R Bradford,Michael J Brenner

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery（2022）

引用 7|浏览10

暂无评分

摘要

SCS use for SSNHL, Bell's palsy, laryngotracheal edema, and perioperative care should follow prepandemic standards. Local or topical corticosteroids are preferable for most other otolaryngologic indications. Whether SCSs attenuate response to vaccination against COVID-19 or increase susceptibility to SARS-CoV-2 infection is unknown. Immunosuppression may lower vaccine efficacy, so immunocompromised patients should adhere to recommended infection control practices. COVID-19 vaccination with Pfizer-BioNTech, Moderna, or Johnson & Johnson vaccines is safe for immunocompromised patients.

查看译文

关键词

Bell palsy,Bell’s palsy,COVID-19,ERAS,SARS-CoV-2,adenoid,cancer,chemoradiation,coronavirus,corticosteroid,dupilumab,edema,enhanced recovery after surgery,facia palsy,facial paralysis,head and neck,hearing loss,inflammation,interleukin 4,laryngotracheal stenosis,mRNA vaccine,nasal polyposis,nausea,osteoradionecrosis,otitis media,pediatric,perioperative,posterior glottic stenosis,radiation,rhinology,rhinosinusitis,severe acute respiratory syndrome,sinonasal,sinusitis,steroid,subglottic stenosis,sudden sensorineural hearing loss,tonsillectomy,tracheostomy,vaccination,vaccine,vomiting

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要